Adjunct Associate Professor of Pharmacy
University of New Mexico Health Sciences Center
Albuquerque, New Mexico, United States
Charles “Kurt” Mahan, PharmD, PhC, FASHP, FCCP is an Adjunct Associate Professor of Pharmacy at University of New Mexico (UNM) where he also received his Doctor of Pharmacy (PharmD) degree. He is a clinical pharmacist and has served in a multitude of roles including administrative, research, and clinical roles in cardiology and cardiac critical care with 3 decades of experience in integrated healthcare systems. He served for 7 years on the National Quality Forum’s (NQF) Cardiovascular Steering Committee for US Performance Measure Endorsement and Maintenance. Dr. Mahan also served in 2023 on the transition committee for performance measure decision making from NQF to Partnership for Quality Measurement (PQM) and on PQM's Advisory Committee and Recommendations Committee for Management of Acute and Chronic Events Group for US Performance Measures until October of 2025. Dr. Mahan has also served as Chair and Vice-Chair for American Society of Health System Pharmacists (ASHP) Council on Therapeutics and been a member of the Pharmacy Accountability Measures Workgroup since 2016. Dr. Mahan completed a North American Thrombosis Forum (NATF) travelling fellowship at McMaster University in Canada where he externally validated the IMPACT-ILL Venous Thromboembolism (VTE) model that subsequently gained widespread international acceptance for VTE prevention and specializes in antithrombotic therapy, reversal of anticoagulation, bleed management and cardiology. He is currently employed as a Customer Engagement Leader for Astra-Zeneca supporting andexanet specifically and has published several book chapters and over 50 peer reviewed publications and is a Fellow of both the American Society of Health-System Pharmacists (FASHP) and the American College of CHEST Physicians (FACP). He is on the editorial board and a Senior Editor for Clinical Applied Thrombosis and Hemostasis and also an editorial board member for Journal of Pharmacy Practice.
Tuesday, June 25, 2024
13:45 – 14:45 ICT